Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | BRCA1 | P38398 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.36 |
| ▸ | CASP7 | P55210 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | THRA | P10827 | 2/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3083464 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL28748436 | 1.00 | ALDH1A1 (0.36) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL9049427 | 0.93 | MAPT (0.41) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL17088436 | 0.90 | ALDH1A1 (0.35) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL14533587 | 0.87 | MEN1 (0.35) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL3088005 | 0.84 | ALDH1A1 (0.37) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL9003751 | 0.82 | POLB (0.39) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL8923831 | 0.80 | ESR1 (0.45) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL14111397 | 0.79 | DPP4 (0.38) | ALDH1A1HSD17B10MEN1USP2MAPT | |
| SCHEMBL3074316 | 0.79 | DPP4 (0.38) | ALDH1A1HSD17B10MEN1USP2MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105646528-A | Soluble bithiophene derivative and preparation and application thereof | 中国中化股份有限公司 | 2016-06-08 | — | — | CN | claimed |
| US-11174211-B2 | Aryl compounds and polymers and methods of making and using the same | NEVADA RESEARCH & INNOVATION CORPORATION (US) | 2021-11-16 | — | — | US | disclosed |
| US-20200331831-A1 | ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, (US) | 2020-10-22 | — | — | US | disclosed |
| US-10550056-B2 | Aryl compounds and polymers and methods of making and using the same | BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) | 2020-02-04 | — | — | US | disclosed |
| WO-2016149633-A1 | ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION, ON BEHALF OF THE UNIVERSITY OF NEVADA, RENO (US) | 2016-09-22 | — | — | WO | disclosed |
| CN-105646528-A | Soluble bithiophene derivative and preparation and application thereof | 中国中化股份有限公司 | 2016-06-08 | — | — | CN | disclosed |
| US-8410150-B2 | Inhibitors of carnitine palmitoyltransferase and treating cancer | UNIVERSITY HEALTH NETWORK (CA) | 2013-04-02 | — | — | US | disclosed |
| US-20100105900-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | UNIVERSITY HEALTH NETWORK | 2010-04-29 | — | — | US | disclosed |
| WO-2008109991-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | UNIVERSITY HEALTH NETWORK (CA) | 2008-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200331831-A1 | ARYL COMPOUNDS AND POLYMERS AND METHODS OF MAKING AND USING THE SAME | AHR, TYR, PAH | ALDH1A1 187/4885HSD17B10 1242/4885MEN1 4482/4885 |
| US-20100105900-A1 | INHIBITORS OF CARNITINE PALMITOYLTRANSFERASE AND TREATING CANCER | CPT1A, CPT1B, CPT2 | ALDH1A1 236/4885HSD17B10 112/4885MEN1 3665/4885 |
| US-11174211-B2 | Aryl compounds and polymers and methods of making and using the same | AHR, TYR, PAH | ALDH1A1 187/4885HSD17B10 1242/4885MEN1 4482/4885 |
| US-10550056-B2 | Aryl compounds and polymers and methods of making and using the same | AHR, TYR, PAH | ALDH1A1 187/4885HSD17B10 1242/4885MEN1 4482/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.